SEROEPIDEMIOLOGICAL CORRELATIONS OF ANTIBODIES TO HUMAN HERPESVIRUSES AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN AFRICAN PATIENTS

被引:10
作者
ESSERS, S [1 ]
SCHWINN, A [1 ]
TERMEULEN, J [1 ]
VONLIPS, H [1 ]
DIETZ, K [1 ]
MHALU, FS [1 ]
SHAO, J [1 ]
TERMEULEN, V [1 ]
机构
[1] UNIV WURZBURG,INST VIROL & IMMUNOBIOL,VERSBACHERSTR 7,W-8700 WURZBURG,GERMANY
关键词
African patients; Herpesviruses; HIV-1;
D O I
10.1007/BF00218678
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A seroepidemiological evaluation of the humoral immune response against human herpes viruses was carried out in patients with and without HIV infection in Tanzania to study the role of these viruses as a cofactor in AIDS. Serum specimens were obtained from 321 outpatients and 100 healthy schoolchildren of a rural population in the Kagera Region, Tanzania, and from 149 inpatients of an urban population in Dar-es-Salaam, Tanzania. The data were analysed by logistic models taking into account demographic variables. The data obtained revealed no differences in the prevalence of antibodies to human herpes viruses between the different groups. Therefore, our study under the present conditions and the observed stages of AIDS does not suggest an influence of HIV infection on human herpesvirus infection or serologic response.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 30 条
  • [1] Ablashi D.V., Josephs S.F., Buchbinder A., Hellman K., Nakamura S., Llana T., Lusso P., Kaplan M., Dahlberg J., Memon S., Imam F., Ablashi K.L., Markham P.D., Kramarsky B., Krueger G.R.F., Biberfeld P., Wong-Staal F., Salahuddin S.Z., Gallo R.C., Human B-lymphotropic virus (human herpesvirus-6), Journal of Virological Methods, 21, pp. 29-48, (1988)
  • [2] Buchwald D., Sullivan J.L., Komaroff A.L., Frequency of chronic active Epstein-Barr Virus Infection in a General Medical Practice, JAMA, 257, pp. 2303-2307, (1987)
  • [3] Duclos H., Elfassi E., Michelson S., Arenzana-Seisdedos F., Virelizier J.L., Cytomegalovirus Infection and Trans-Activation of HIV-1 and HIV-2 LTRs in Human Astrocytoma Cells, AIDS RESEARCH AND HUMAN RETROVIRUSES, 5, pp. 217-224, (1989)
  • [4] Efstathiou S., Gompels U.A., Craxton M.A., Honess R.W., Ward K., Lancet, pp. 63-64, (1988)
  • [5] Gendelmann HE., Phelps W., Feigenbaum L., Ostrove J.M., Adachi A., Howley P.M., Khoury G., Ginsberg H.S., Martin M.A., Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses, Proceedings of the National Academy of Sciences, 83, pp. 9759-9763, (1986)
  • [6] Hinuma Y., Kohn M., Yamaguchi J., Wudarski D.J., Blakeslee J.R., Grace J.T., Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line, J. Virol., 1, pp. 1045-1051, (1967)
  • [7] Holmberg S.D., Gerber A.R., Stewart JA., Lee E.K., O'Malley P.M., Nahmias A.J., Lancet, pp. 746-747, (1988)
  • [8] Huemer P.H., Larcher C., Wachter H., Dierich M.P., Prevalence of Antibodies to Human Herpesvirus 6 in Human Immunodeficiency Virus 1 Seropositive and Negative Intravenous Drug Addicts, J. Infect. Dis., 160, pp. 549-550, (1989)
  • [9] Krueger G.R.F., Koch B., Ramon A., Ablashi D.V., Salahuddin S.Z., Josephs S.F., Streicher HZ., Gallo R.C., Habermann U., Antibody prevalence to HBLV (HHV-6) and suggestive pathogenicity in the general population and in patients with immunodeficiency syndromes, J. Virol. Meth., 21, pp. 125-131, (1988)
  • [10] Krueger G.R.F., Ramon A., Overview of immunopathology of chronic active herpesvirus infection, J. Virol. Meth., 21, pp. 11-18, (1988)